Based on the FIP Health Advisory – Coronavirus SARS-CoV-2/COVID-19 Pandemic: Information and interim guidelines for pharmacists and the pharmacy workforce and Australian governments resources and advisories
The Guild’s Pandemic Planning Checklist may assist members in preparing their pharmacy and workforce with regards to business continuity, service provision and contingency arrangements for COVID-19.
The preparation of this guide by the Pharmacy Guild of Australia is intended to be a supporting resource to provide pharmacists with information to assist them in safely operating their pharmacy and meeting community needs during the COVID-19 pandemic.
The Guild recognises that each pharmacy is unique and will need to innovate and adapt guidance relevant to their pharmacy and circumstances and following a risk assessment for their pharmacy, as well as in accordance with any direction provided by Commonwealth, State or Territory authorities.
These Guidelines do not replace the need for pharmacists to exercise professional discretion and judgement and to comply with relevant laws and professional standards and codes. The Guidelines do not include detailed legislative requirements with regards pharmacy practice.
The COVID-19 pandemic situation is evolving rapidly with information and advice being provided or updated constantly. As such, to maintain currency these documents will be periodically reviewed and updated. It is important the reader ensure they are reading and using the most up to date version.
The Pharmacy Guild of Australia welcomes suggestions or improvements to our resources, especially if a reader identities any inaccuracies or ambiguities.
We also encourage members to research or utilise resources available through various government agencies in the development of business continuity plans and risk management practices.
Your Guild Branch is the best source of specific guidance and information relevant to pharmacy practice, operations, or jurisdictional directives. Please contact them for any queries. Use official resources and websites, particularly www.health.gov.au, www.australia.gov.au, or your state/territory government websites.
For guidance and information on your pharmacy's vaccination readiness, go to the Guild's PRODA, HPOS and AIR page.
Every pharmacy owner should have a business continuity plan outlining how their pharmacy will continue to operate during an unplanned service disruption.
To complement any business continuity plan, the Guild has also developed a Pandemic Planning template to assist pharmacists in preparing for unplanned contingencies associated with a pandemic such as COVID-19. This can be used by pharmacists to develop their own specific pandemic plan which reflects the individual requirements of their pharmacy and community.
This Guide provides practical information, guidance and procedures for community pharmacies in Australia to ensure their staff stay safe, well, and can continue to provide essential services for the duration of the pandemic and should be used in conjunction with the pharmacy’s business continuity plan and COVID-19 pandemic plan.
Pharmacies are considered essential services during the COVID-19 pandemic, so closure of the pharmacy or a change to operating hours due to staff shortages or infection, may or will have a number of implications that pharmacy owners will need to consider carefully before making any decision.
These may include, and are not limited to, considerations or requirements such as:
Speak to your Guild Branch for specific guidance.
Any changes to the operation of the pharmacy should be clearly communicated to the community and relevant stakeholders. Wherever possible, communicate when the pharmacy will reopen, if known.
Continuity of care for patients of the pharmacy should be planned and clearly communicated.
These patients could include those:
Consider collaborating with surrounding pharmacies to roster opening hours.
In order to assure the health of pharmacy staff and therefore continuity of supply of medicines and services to communities, especially where there is only one pharmacy within a town, contact with patients/consumers may need to be managed to minimise contact, however possible.
Options to consider
Pharmacies may consider any of the below approaches and activities or a combination of these, as is practical and realistic in their pharmacy. There may be specific advice or direction from Commonwealth or State/Territory authorities, which may change as the situation evolves.
The Australian Government has advised that Australia is well set up to ensure continuity of medicines supply and that there is no reason for people to unnecessarily stockpile medicines. Pharmacies have a critical role is ensuring access to medicines during the Pandemic while managing unreasonable requests that could potential precipitate a national shortage.
The Guild and Pharmaceutical Society have supported the Government’s request that pharmacists enforce new limits on dispensing and sales of prescription and OTC medicines.
Pharmacists are requested to limit request for prescription medicines to one supply only at any one time. For most PBS medicines, this generally means a patient will have one month’s supply. As with any medicine shortage, if local supplies are disrupted, pharmacists should use their professional judgement and there may be times when pharmacists can only supply part of the pack with a balance owing when orders are fulfilled. Likewise, for prescriptions for larger quantities, pharmacists should use their professional discretion based on stock availability.
Similarly, pharmacists have been requested to limit the sale of OTC medicines to only one pack at a time. Pharmacists still need to ensure supply is safe and appropriate and based on therapeutic need, consistent with legislation and professional standards.
As restocking delays have particularly affected supplies of salbutamol inhalers and children’s analgesics, additional measures have been put in place for these medicines:
Since January 2019, there is legislative requirements for medicine sponsors to notify the TGA of a medicine shortage, including a potential shortage. Details of prescription shortages are promptly recorded on the TGA website.
If pharmacies are experiencing a supply issue relating to a particular prescription medicine and it is not listed on the TGA website, it is most likely a local supply disruption. If the disruption is prolonged and there is no information published, pharmacists should notify the TGA via email@example.com.
If possible, deliveries to the pharmacy should occur without any external parties entering the pharmacy (or at least the non-public areas of the pharmacy).
Delivery containers/tubs should be cleaned and disinfected before being taken inside the pharmacy if possible.
Pharmacies may consider home delivery of essential medicines and other products to support the community, especially those in home quarantine or self-isolating due to being in a vulnerable group or with reduced mobility.
Under the National Health Act 1953 (Cth), approved pharmacists are able to charge a discretionary fee for the delivery of a PBS medicine. Providing a delivery service should be at the discretion of the pharmacy owner or manager and will be influenced by the staffing capabilities and potential staff absence from the pharmacy. Delivery services should also ensure the safety of the delivery personnel.
Any delivery service should follow professional guidelines and existing pharmacy procedures (e.g. QCPP requirements) and ensure that there is not two-way transmission of the virus between delivery personnel and patients.
The Guild is developing a specific COVID-19 Home Delivery Service protocol which considers all factors such as resources, costs, infection control procedures, and logistics. This will be added to the Guild website as soon as it is finalised.
Staff who are infected with COVID-19 should follow advice provided by the local health authorities and their medical team.
It is likely that their employer will be notified by health authorities and provided with specific instructions and advice.
The Guild is currently waiting on general advice to provide to members regarding issues such as the need to potentially close the pharmacy, and any infection on decontamination requirements. This information will be made available as soon as it is confirmed.
Consider not allowing patients to self-select products to avoid multiple people touching these products. Pharmacies may wish to discourage this, and general browsing by cordoning off areas of the pharmacy and restricting access to pharmacy personnel only. Consider removing product testers from shelves.
External and internal signage at the pharmacy is vital to communicate health messages or changes to service procedures. The Guild has developed a number of posters for use by pharmacies, and these may be national or state/territory specific.
Signs and posters may include:
Consider the following suggestions to minimise virus transmission:
Many pharmacists are concerned with the increased transmission risk associated with sharing pens to sign for receipt of prescriptions. This is a legitimate concern given the duty of care to keep patients and staff safe.
Under the National Health Act, patients or agents must sign for receipt of their medicines to substantiate a claim for payment. If it is not practical to obtain a signature, a pharmacist may annotate the prescription. If a pharmacy is audited, they may need to provide a signed or annotated prescription.
The Guild has requested from the Government an exemption to this requirement while COVID remains a risk and is awaiting a response.
In the meantime, if pharmacists decide to stop obtaining signatures as a risk management strategy, they should consider how they are prepared for any audits. As an example, some pharmacists are ordering stamps against which a pharmacist can quickly countersign.
Consider the following suggestions to promote social distancing:
It is important to designate a lead pharmacist to provide professional oversight and leadership and to coordinate the pharmacy’s response. Additionally, a managing pharmacist should be identified to provide supervision of all activities and all staff for each shift.
Influenza vaccination is an important measure to prevent influenza and its complications and is especially important during the COVID-19 pandemic, particularly for front line healthcare workers and at risk people.
Encouraging all pharmacy staff to have an influenza vaccine is important to best protect them from influenza.
Pharmacies should consider their own risk management, operational and business continuity plans when deciding whether they will provide vaccination services during the COVID-19 pandemic.
Pharmacy owners are obliged to ensure they provide a safe working environment for their staff. Additional precautions should be considered to protect staff and patients when providing vaccination services at this time. There has been no specific advice regarding PPE issued from relevant authorities to date.
In addition to existing professional guidelines or pharmacy procedures, pharmacists administering vaccines may consider the following:
Pharmacists and pharmacy assistants can play a significant role in preventing the spread of COVID-19.
They can do this by:
Wearing a surgical mask is one of the prevention measures to limit spread of COVID-19 in affected areas. However, the use of a mask alone may be insufficient to provide an adequate level of protection and other relevant measures should be considered based on relevant advice from the authorities.
If worn properly, a mask helps block respiratory secretions produced by the wearer from contaminating other people and surfaces.
Currently, the Chief Medical Officer, advises that ‘masks are not currently recommended for use by healthy members of the public for the prevention of infections like coronavirus.’
The Department of Health recommends the use of additional PPE (e.g. gowns, protective eyewear or gloves) only when treating a confirmed or epidemiologically suspected COVID-19 case.
*Note: The contents of this page are under review. For the updated advice regarding masks and other PPEs, please navigate to COVID-19 Infection Control.
Pharmacists have a pivotal role to play in public health and informing the community about preventive measures, advising about behavioural changes and in the risk assessment, early detection and referral of individuals at higher risk of being infected.
Information should be current, based on sound scientific evidence or official advice and not driven by panic.
In all cases, it is critical that pharmacists and pharmacy staff protect themselves from infection by keeping a safe distance from patients and members of the public and frequently disinfecting any surfaces that may be touched by them.
Since COVID-19 infection can occur from asymptomatic or pre-symptomatic individuals, precaution is recommended with ALL patients entering the pharmacy.
See Guild website for resources or links for managing suspected or confirmed cases of COVID-19.
Note: While travel history from affected areas is still an important criterion, it will no longer be a relevant criterion for triage when community-based transmission becomes the main form of disease transmission.
COVID-19 is transmitted through droplets and contact, therefore it is imperative that any areas of the pharmacy that may have been contaminated with the virus are disinfected.
Pharmacy staff should implement procedures for cleaning and disinfecting the working environment, and associated items and equipment.
Cleaning refers to the removal of germs, dirt, and impurities from surfaces. It does not kill germs, but by removing them, it lowers their numbers and the risk of spreading infection.
Disinfecting refers to using chemicals to kill germs on surfaces. This process does not necessarily clean dirty surfaces or remove germs, but by killing germs on a surface after cleaning, it can further lower the risk of spreading infection.
Further resources on cleaning and disinfection procedures will be provided shortly.
This information is correct as of 24 March 2020 and will be updated as necessary.